This is to inform that the Resolution Plan Implementation Committee, in its meeting held today, viz. Sunday, February 01, 2026, which commenced at 06:00 P.M. (IST) and concluded at 07:18 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare has completed its exit from the Corporate Insolvency Resolution Process (CIRP). The NCLT Mumbai approved the resolution plan submitted by Mr. Pradeep Kumar Jain on December 18, 2025, and the total bid value of ₹37.30 crores has now been received in escrow and used to settle financial creditors, operational creditors, workmen, and employees. The Resolution Plan Implementation Committee stood dissolved on February 1, 2026, and all powers have been transferred to the Interim Board. The Committee also approved audited consolidated financial results for FY ended March 31, 2025, showing revenue of ₹31.07 crores, a net loss of ₹25.98 crores, and EPS of ₹(10.39). The auditor issued a Disclaimer of Opinion due to multiple unresolved matters including going concern uncertainty, unreconciled loans of ₹33.11 crores, inventory valuation gaps, and the subsidiary Dr. Smith's Biotech also being under CIRP.
This is a positive milestone — the company has formally emerged from insolvency with creditors fully settled and a new Board taking charge, which should restore normal trading and corporate governance. However, shareholders should note the heavy losses, the auditor's qualified opinion, and the uncertain status of the subsidiary still under CIRP, which could weigh on near-term fundamentals.